BlackRock Inc (BLAK34)
Sao Paulo Exchange · Brazil · prices in BRL · close of 19 Oct 2026
Key indicators
| Last close | BRL 86.06 |
|---|---|
| 52-week range | 72.28 – 99.39 |
| Return, 1 month / 3 months | +4.8% / +5.7% |
| Return, 1 year / 3 years | −9.3% / +79.8% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 56 |
| Volatility (1 year) | 30.8% |
| Worst drawdown (1 year) | -25.3% |
| Average daily value traded | 0.20M BRL |
| Dividend yield | 1.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
BlackRock is an investment management company based in the United States. It provides asset management services to institutional clients and individual investors around the world, including mutual funds, exchange-traded funds and advisory services. Its iShares business offers funds that track market indexes, and its platform also supplies risk management and investment technology tools to other financial firms. The company manages money across equities, bonds and other asset classes on behalf of pension funds, governments, companies and savers.
BlackRock Inc is represented on the Sao Paulo Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code BLAK34, with its price quoted in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
BlackRock Inc (BLAK34) trades on the Sao Paulo Exchange in Brazil. It last closed at BRL 86.06 on 19 October 2026.
Its price-based Market X-Ray is 61 out of 100 (a fair price profile), ranking 423 of 1,454 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 9.3% and over the last three months it rose 5.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Sao Paulo Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 63 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 4.3% | ||
| From 52-week high | -12.3% | ||
| Momentum | 52 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 5.7% | ||
| 6-month return | 9.0% | ||
| 12-month return, skipping the last month | -13.4% | ||
| Stability (higher is calmer) | 68 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 30.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -25.3% | ||
| Liquidity | 70 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.20M BRL | ||
| Zero-volume days | 0.0% | ||
| Income | 47 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.1% | ||
| Years with dividends | 6 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | +5.2% |
|---|---|
| 1 month | +4.8% |
| 3 months | +5.7% |
| 6 months | +9.0% |
| 1 year | −9.3% |
| 3 years | +79.8% |
| 5 years | – |
Signals
| 50-day / 200-day average | 86.19 / 82.54 |
|---|---|
| Golden / death cross (60 days) | Golden, 40 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.45 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 2 Jun 2026 | USD 0.3059 |
| 4 Mar 2026 | USD 0.3070 |
| 3 Dec 2025 | USD 0.2959 |
| 3 Sep 2025 | USD 0.2834 |
| 3 Jun 2025 | USD 0.2933 |
| 5 Mar 2025 | USD 0.3043 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Sao Paulo Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.